Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulated ANLN reveals immune cell landscape and promotes carcinogenesis by regulating the PI3K/Akt/mTOR pathway in clear cell renal cell carcinoma. | Heliyon | 2024 | 38173514 | PubTator, text mining | PubMed |
| Identification of basement membrane-related signatures for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma. | J Cancer | 2024 | 38169540 | PubTator, text mining | PubMed |
| Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: an exploratory study. | BMC Infect Dis | 2024 | 38166667 | PubTator, text mining | PubMed |
| Protective fibroblastic niches in secondary lymphoid organs. | J Exp Med | 2024 | 38038708 | PubTator, text mining | PubMed |
| Ceramide metabolism-related prognostic signature and immunosuppressive function of ST3GAL1 in osteosarcoma. | Transl Oncol | 2024 | 38029509 | PubTator, text mining | PubMed |
| Unraveling the genetic associations between PD-1/PD-L1 and 13 circulating biomarkers linked to physiological and pathological processes. | Clin Transl Oncol | 2024 | 37971626 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals cuproptosis and mitochondria-based signature for assessing prognosis and immune landscape in osteosarcoma. | Front Immunol | 2023 | 38250070 | PubTator, text mining | PubMed |
| Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies. | Front Immunol | 2023 | 38235128 | PubTator, text mining | PubMed |
| New Cardiovascular Biomarkers in Breast Cancer Patients Undergoing Doxorubicin-Based Chemotherapy. | Arq Bras Cardiol | 2023 | 38232245 | PubTator, text mining | PubMed |
| How Do Classical Subtypes Correspond to Endotypes in Atopic Dermatitis? | Int J Mol Sci | 2023 | 38203432 | PubTator, text mining | PubMed |
| The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis. | Int J Mol Sci | 2023 | 38203309 | PubTator, text mining | PubMed |
| Inflammatory immune profiles associated with disease severity in pulmonary tuberculosis patients with moderate to severe clinical TB or anemia. | Front Immunol | 2023 | 38162636 | PubTator, text mining | PubMed |
| A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia. | Front Mol Biosci | 2023 | 38161382 | PubTator, text mining | PubMed |
| Comprehensively prognostic and immunological analysis of VRK Serine/Threonine Kinase 1 in pan-cancer and identification in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 38157278 | PubTator, text mining | PubMed |
| Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis. | Int J Mol Sci | 2023 | 38139427 | PubTator, text mining | PubMed |
| CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies. | Int J Mol Sci | 2023 | 38139340 | PubTator, text mining | PubMed |
| All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia. | Medicina (Kaunas) | 2023 | 38138273 | PubTator, text mining | PubMed |
| Construction of monocyte-related prognosis model based on comprehensive analysis of bulk RNA-seq and single-cell RNA-seq in high-grade serous ovarian cancer. | Medicine (Baltimore) | 2023 | 38115318 | PubTator, text mining | PubMed |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy. | Front Immunol | 2023 | 38090565 | PubTator, text mining | PubMed |
| Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics. | Cancer Med | 2023 | 38083903 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=10